Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat

Journal of Biochemical and Molecular Toxicology

Volumn 21, Issue 1, 2007, Pages 41-50

  Elbarbry, Fawzy A ^a   McNamara, Patrick J ^b   Alcorn, Jane ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

CYP1A2; CYP2E1; Interspecies Extrapolation; Liver; Ontogeny; Rat

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; LIVER ENZYME; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER; LIVER TOXICITY; MALE; NEWBORN; NONHUMAN; ONTOGENY; PERINATAL PERIOD; PROTEIN EXPRESSION; PUBERTY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES COMPARISON; TOXICOKINETICS; WEANING;

AGING; ANIMALS; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; OXIDOREDUCTASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS;

EID: 34147103938     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20156     Document Type: Article

References (40)

1. Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 2002;41(12):959-998.
2. Clark LH, Setzer RW, Barton HA. Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal 2004;24(6):1697-1717.
3. Ginsberg G, Haitis D, Miller R, Sonawane B. Pediatric pharmacokinetic data: Implications for environmental risk assessment for children. Pediatrics 2004;113(Suppl 4):973-983.
4. Ginsberg G, Slikker W Jr., Bruckner J, Sonawane B. Incorporating children's toxicokinetics into a risk framework. Environ Health Perspect 2004;112(2):272-283.
5. Brent RL. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Birth Defects Res B Dev Reprod Toxicol 2004;71(5):303-320.
6. Ioannides C, Parke DV. The cytochrome P450 I gene family of microsomal hemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 1990;22(1):1-85.
7. Novak RF, Woodcraft KJ. The alcohol-inducible form of cytochrome P450 (CYP 2E1): Role in toxicology and regulation of expression. Arch Pharm Res 2000;23(4):267-282.
8. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. Faseb J 1992;6(2):724-730.
9. Lieber CS. Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 1997;77(2):517-544.
10. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 2006;69(1):140-153.
11. Lindros KO. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver. Gen Pharmacol 1997;28(2):191-196.
12. Oinonen T, Mode A, Lobie PE, Lindros KO. Zonation of cytochrome P450 enzyme expression in rat liver. Isozyme-specific regulation by pituitary dependent hormones. Biochem Pharmacol 1996;51(10):1379-1387.
13. Rich KJ, Boobis AR. Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 1997;39(5):424-135.
14. Shapiro BH, Agrawal AK, Pampori NA. Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol 1995;27(1);9-20.
15. Chang TK, Bellward GD. Peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase: Pretranslational regulation and impact on microsomal drug activation. J Pharmacol Exp Ther 1996;278(3):1383-1391.
16. Dhir RN, Dworakowski W, Thangavel C, Shapiro BH. Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 2006;316(1):87-94.
17. Iba MM, Soyka LF, Schulman MP. Characteristics of the liver microsomal drug-metabolizing enzyme system of newborn rats. Mol Pharmacol 1977;13(6):1092-1104.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
19. Court MH, Von Moltke LL, Shader RI, Greenblatt DJ. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm Drug Dispos 1997;18(3):213-226.
20. Hanioka N, Tatarazako N, Jinno H, Arizono K, Ando M. Determination of cytochrome P450 1A activities in mammalian liver microsomes by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl 2000;744(2):399-106.
21. Koop DR, Tierney DJ. Multiple mechanisms in the regula-tion of ethanol-Lnducible cytochrome P450IIE1. Bioessays 1990;12(9):429-135.
22. Tanaka E, Terada M, Misawa S. Cytochrome P450 2E1: Its clinical and toxicological role. J Clin Pharm Ther 2000;25(3):165-175.
23. Borlakoglu JT, Scott A, Henderson CJ, Wolf CR. Expression of P450 isoenzymes during rat liver organogenesis. Int J Biochem 1993;25(11):1659-1668.
24. Carpenter SP, Savage DD, Schultz ED, Raucy JL. Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver. J Pharmacol Exp Ther 1997;282(2):1028-1036.
25. Czekaj P, Wiaderkiewicz A, Florek E, Wiaderkiewicz R. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Arch Toxicol 2005;79(1):13-24.
26. Ejiri N, Katayama K, Doi K. Induction of cytochrome P450 isozymes by phénobarbital in pregnant rat and fetal livers and placenta. Exp Mol Pathol 2005;78(2):150-155.
27. Giachelli CM, Omiecinski CJ. Developmental regulation of cytochrome P-450 genes in the rat. Mol Pharmacol 1987;31(5):477-484.
28. Couroucli XI, Liang YW, Jiang W, Barrios R, Moorthy B. Attenuation of oxygen-induced abnormal lung maturation in rats by retinoic acid: Possible role of cytochrome P4501A enzymes. J Pharmacol Exp Ther 2006;317(3):946-954.
29. Umeno M, Song BJ, Kozak C, Gelboin HV, Gonzalez FJ. The rat P450IIE1 gene: Complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′ cytosine demethylation. J Biol Chem 1988;263(10):4956-4962.
30. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpaa J, Rane A, Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994;48(1):59-64.
31. Maenpaa J, Rane A, Raunio H, Honkakoski P, Pelkonen O. Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse. Biochem Pharmacol 1993;45(4):899-907.
32. Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, Inui Y. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 1996;24(5):515-522.
33. Vieira I, Sonnier M, Cresteil T. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. Eur J Biochem 1996;238(2):476-83.
34. Johnson TN, Tanner MS, Tucker GT. Developmental changes in the expression of enterocytic and hepatic cytochromes P4501A in rat. Xenobiotica 2002;32(7):595-604.
35. Ratanasavanh D, Beaune P, Morel F, Flinois JP, Guengerich FP, Guillouzo A. Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991;13(6):1142-1151.
36. Sonnier M, Cresteil T. Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem 1998;251(3):893-898.
37. Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther 2003;307(1):402-07.
38. Anand SS, Kim KB, Padilla S, Muralidhara S, Kim HJ, Fisher JW, Bruckner JV. Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: Role in age-dependent acute neurotoxicity. Drug Metab Dispos 2006;34(3):389-397.
39. Jahn F, Reuter A, Karge E, Danz M, Klinger W. Age dependent different influence of carbon tetrachloride on biotransformation of xenobiotics, glutathione content, lipid peroxidation and histopathology of rat liver. Exp Toxicol Pathol 1993;45(2-3):101-107.
40. Shimamoto A, Tanaka E, Mizuno D, Misawa S. Age- and sex-related changes in toluene metabolism by rat hepatic microsomes in vitro. Res Commun Mol Pathol Pharmacol 1999;104(3):265-276.